Skip to content
Open access

Evaluation of pre-myopia risk factors in children aged 6-10 years: pediatric vision screening

Sep 2026 · Turkish Journal of Family Practice · 0 citations · 33 references

Abstract

Background: The aim of this study was to evaluate pre-myopia risk factors in children aged 6–10 years and to investigate whether a simple risk-based questionnaire could help identify children at increased risk of pre-myopia in primary healthcare settings. Methods: This cross-sectional study was conducted in Erzurum, Türkiye, over a three-week period beginning on October 28, 2025. A total of 652 children were invited to participate in the study; those with active visual complaints and those not within the 6–10 age range were excluded. A total of 453 children who met the inclusion criteria were analyzed. Based on questionnaire scores, low-, medium-, and high-risk groups were formed; biometric measurements of 44 children in the high-risk group who attended the examination were evaluated. The relationships between risk groups and demographic variables were analyzed using the chi-square test, and the relationship between biometric parameters and SE was assessed using Pearson correlation. An AL/CR ratio ≥ 2.90 was accepted as the biometric high-risk threshold. Sample adequacy was verified using G*Power 3.1. Results: The mean age was 7.91 ± 1.26 years, and 51.7% of participants were male. The mean AL/CR ratio in the examined children was 2.90 ± 0.12. SE values ranged from −0.50 to +0.50 D, indicating that all examined children were within the refractive pre-myopia range. No significant correlation was found between questionnaire risk score and AL/CR ratio (Pearson r = −0.08, p = 0.666) or SE (Pearson r = −0.11, p = 0.535). Questionnaire risk score was not a significant predictor of an AL/CR ratio ≥2.90 in univariable logistic regression analysis (OR = 1.14, 95% CI: 0.64–2.03; p = 0.67). Conclusion: The findings suggest that a simple risk-based questionnaire may assist primary care physicians in identifying children who could benefit from ophthalmologic evaluation. Further validation studies are required before routine implementation.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.